RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $183
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on Tenet Healthcare (NYSE:THC) and raised the price target from $174 to $183.
October 30, 2024 | 4:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reaffirmed its 'Outperform' rating for Tenet Healthcare and increased the price target to $183, indicating confidence in the company's future performance.
The increase in price target from $174 to $183 by RBC Capital suggests a positive outlook on Tenet Healthcare's future performance. The 'Outperform' rating indicates that the analyst expects the stock to perform better than the market average, which could lead to increased investor interest and a potential rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100